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Abstract
Purpose—Alcohol is an established breast cancer risk factor, but there is little evidence on 
whether the association differs between African Americans and whites.
Methods—Invasive breast cancers (n=1,795; 1,014 white, 781 African American) and age- and 
race-matched controls (n= 1,558; 844 white, 714 African American) from the Carolina Breast 
Cancer Study (Phases I–II) were used to estimate odds ratios (ORs) and 95% confidence intervals 
(CIs) for pre-diagnosis drinks per week and breast cancer risk.
Results—African American controls reported lower alcohol intake than white controls across all 
age groups. Light drinking (0-≤2 per week) was more prevalent among African American controls. 
Moderate to heavy drinking was more prevalent in white controls. African Americans who 
reported drinking >7 drinks per week had an elevated risk compared to light drinkers [adjusted 
OR, 95% CI: 1.62 (1.03–2.54)]. A weaker association was observed among whites [adjusted OR, 
95% CI: 1.20 (0.87–1.67)]. The association of >7 drinks per week with estrogen receptor negative 
[adjusted OR, 95% CI: 2.17 (1.25–3.75)] and triple negative [adjusted OR, 95% CI: 2.12 (1.12–
4.04)] breast cancers was significant for African American, but not white women. We observed 
significantly elevated ORs for heavy intake at ages less than 25 and greater than 50 years of age 
for African American women only. We found no evidence of statistical interaction between 
alcohol intake with oral contraceptive use or smoking.
Conclusions—Drinking more than 7 alcoholic beverages per week increased invasive breast 
cancer risk among white and African American women, with significant increases only among 
African American women. Genetic or environmental factors that differ by race may mediate the 
alcohol-breast cancer risk association.
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INTRODUCTION
Alcohol is an established risk factor for breast cancer, with studies showing elevated risk in 
those with the highest levels of intake1–5. Results regarding never drinkers have been mixed; 
both null results and increased risk of breast cancer have been observed 1–4,6,7. However, 
most of these studies have been conducted primarily on white women1–3. There is evidence 
that drinking patterns differ by race in the United States, with blacks reporting less drinking 
than whites6,8–11. Information on differences in risk by race would support targeted public 
health messaging regarding alcohol intake.
Comparison of the alcohol-associated risk between African American and white women can 
be confounded by differing prevalences of breast cancer subtypes within race. African 
American women have higher rates of estrogen receptor (ER) negative breast cancer, and 
may be more likely to develop breast cancers that are triple negative (negative for ER, 
progesterone receptor (PR) and Human Epidermal Growth Factor Receptor 2 (HER2) 
negative. Given evidence that alcohol may alter hormone metabolism12, some studies have 
evaluated risk by ER status, suggesting that alcohol intake is more strongly associated with 
hormone receptor positive (ER+ or PR+) breast cancers1,13.
Early experimental studies of alcohol exposure argued that alcohol may be a co-carcinogen, 
increasing risk only among individuals exposed to other carcinogens. However, this 
hypothesis was dispelled by longer exposures, wherein lifetime exposure to alcohol 
produced carcinogenic effects in animals independent of other carcinogenic exposures10,1. 
Investigating the interaction between oral contraceptive use and alcohol intake is important 
due to biological evidence that alcohol intake may impact levels of bioavailable hormones15. 
Additionally, because smoking may initiate cancer and is more common among alcohol 
users, it is important to evaluate effect modification of the alcohol-breast cancer risk 
association by smoking status. Furthermore, few studies have evaluated specific windows of 
susceptibility to alcohol exposure (i.e., early vs. later life) and none have examined these 
windows of exposure among African American women.
The current study is an update to the previously published analysis using CBCS Phase I 
women only (890 cases and 841 controls6), incorporating 905 invasive breast cancer cases 
and 717 controls from Phase II. Increased sample size allows for increased power when 
stratifying by race, hormone receptor status, and intrinsic breast cancer subtype and allows 
for evaluation of effect modification by duration of oral contraceptive use, smoking status 
and multiple age-defined etiologically relevant windows.
METHODS
Study population
The present analysis includes 3,353 participants from the population-based Carolina Breast 
Cancer Study (CBCS), Phases I (1993–1996) and II (1996–2001). Methods for CBCS have 
been described in detail elsewhere16–21. Briefly, eligible cases were women with a first 
diagnosis of invasive or in situ breast cancer identified through rapid case ascertainment 
through the NC Central Cancer Registry. Controls were selected from North Carolina 
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Department of Motor Vehicles lists for women aged 20 to 64 years and Medicare lists for 
women aged 65 to 74 years. As previously reported for CBCS, cooperation rates were 
similar for women of both races. Cooperation rates for women under the age of 50 were 84 
percent for white cases and 80 percent for African American cases. Cooperation rates for 
women 50 and older were 76 percent for white women and 72 percent for African American 
women22. Frequency matching of cases and controls based on race and 5-year age categories 
was performed. African American and non-African American (>98% white) <50 years of 
age and ≥50 years of age were sampled accounting for sampling fractions to achieve equal 
numbers of women in both categories. The current analysis is restricted to invasive cases of 
breast cancer only resulting in 781 African American and 1,014 white women. We included 
714 African American women and 844 white women as controls.
Tumor subtype for Estrogen Receptor (ER), Progesterone Receptor (PR) and Human 
Epidermal Growth Factor Receptor 2 (HER2) classification was based on a combination of 
pathology data from hospital records and/or Immunohistochemistry (IHC) performed at the 
Immunohistochemistry Core Laboratory at the University of North Carolina (when medical 
record data were missing). Cases were classified as ER+, PR+, or HER2+ if marker 
expression was recorded as positive in the medical record or if staining was positive based 
on contemporaneous clinical standards. Additional details regarding staining are provided by 
O’Brien et al. (2010)23.
Exposure Assessment
The level of alcohol intake was determined by the self-reported drinking in the age category 
that included diagnosis age (for cases) or enrollment age (for controls). For CBCS, type of 
alcohol (beer, wine, liquor) and amount (drinks per day, week, month) was queried for the 
following age ranges for each participant: less than 25 years of age, 25 to 49 years of age, 
and 50 or more years of age. Alcohol intake most proximal to diagnosis was used as the 
main variable of interest. Alcohol intake information was missing for 6 white cases and 2 
controls and 4 African American cases and 7 controls. These 19 individuals were excluded 
from all analyses. To be classified as a never drinker, participants had to report being a never 
drinker for each of the age groups preceding diagnosis. The drinks per week categories were 
as follows, Never Drinkers, 0 to ≤2 drinks per week (referent) (light drinkers), >2 to ≤7 
drinks per week (moderate drinkers), and more than 7 drinks per week (heavy drinkers). 
Categories were determined using The Dietary Guidelines for Americans24.
Multivariable analysis
Logistic regression was used to estimate odds ratios (ORs) as the measure of association 
between alcohol drinking and invasive breast cancer risk. All analyses were done in SAS 
version 9.3 (SAS Institute, Cary, NC). P-values were two-sided with an alpha of 0.05. To 
evaluate statistical interaction between oral contraceptive use (never user,<1 year, 1–9 years, 
10 or more years), smoking status (never, former, current) and reported drinks per week in 
association with invasive breast cancer risk, Wald chi-square statistics and p-values for the 
beta coefficient of the interaction terms between oral contraceptive use, smoking status, and 
categorical drinks per week were assessed for basic (adjusted for 5-year age groups) and full 
(adjusted for 5-year age groups, education, marital status, menopausal status (pre/post), HT 
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use (any/ never), BMI (WHO categories), age at menarche, parity, lactation duration, 
income, smoking status and duration of oral contraceptive use, with each of the latter two 
confounders only included when not stratifying on the same. Separate models were fit for 
African American and white women. Sample size counts in tables are unweighted and the 
associated proportions account for the sampling design of the study. PROC SURVEYFREQ 
was used to determine chi-square statistics and p-values for weighted percentages. Potential 
confounder inclusion was based on substantive area knowledge and Directed Acyclic Graph 
(DAG) construction for relationships between covariates, alcohol and breast cancer25,26. 
These associations were further investigated in the current dataset for associations with 
alcohol intake among the controls and case status among the non-drinkers. We report both a 
basic and a multivariate model because there was no evidence of significant confounding by 
any of the covariates using the 10% change in estimate backward elimination approach or by 
using the Likelihood Ratio Test (LRT) approach. The following covariates were used in the 
logistic regression models based on their hypothesized relationship to both alcohol intake 
and invasive breast cancer and coded as follows: age at diagnosis or study enrollment 
modeled as an ordinal variable (20–24, 25–29, 30–34, 35–39, 40–44, 45–49, 50–54, 55–59, 
60–64, 65–69, 70–74), marital status (single, married, widowed, divorced), level of 
education (0–8 years, 9-<12 years (not high school graduate, high school graduate/GED, 
some college, college graduate (16 years) post-graduate or professional degree), menopausal 
status (pre-/post-), age at menarche (<11 years, 11–12, 13–14, 15–16, 17 or older), parity 
(nulliparous, 1, 2, 3, or 4 or more live births), lactation duration (never breast fed, 0–5 
months, 6–11 months, 12–24 months, greater than 24 months), postmenopausal hormone 
therapy (HT) use (never used, 3+ months), recent Body Mass Index (BMI) was calculated as 
body weight/height squared (kg/m2) and categorized based on the WHO categories 
(underweight, <18.5; normal weight, 18.5–24.9; overweight, 25–29.9; class I obese, 30–
34.9; class II obese, 35–39.9; and class III obese, 40+), history of mammogram (ever, never) 
and income (<$20,000, $20,000–50,000, >$50,000). To account for the sampling design of 
the study, the oversampling of women at younger ages, the CBCS offset term was included 
in PROC LOGISTIC. Participants without alcohol intake information were excluded from 
all analyses. For the logistic models, a complete case analysis was used for the basic and 
multivariate models (resulting in exclusion of approximately 10% of both African American 
and white women in the multivariate model who were missing any of the covariates). Tests 
for linear trend were conducted comparing categories of 0 to ≤2 drinks per week (light 
drinkers, referent), >2 to ≤7 drinks per week (moderate drinkers), and more than 7 drinks per 
week (heavy drinkers) using an ordinal categorical variable set to 0, 1, or 2, respectively.
To examine the association between alcohol intake and breast cancer subtype, we stratified 
on ER status, Luminal A and B subtype combined, Triple Negative breast cancers and Basal-
like subtype. There were too few HER2-positive cases (n= 72) to evaluate the association 
among these cases. Subtype stratification includes only invasive cases where there was 
enough tumor tissue for IHC analysis, resulting in 513 African American cases and 629 
white cases.
To examine whether alcohol drinking at different ages showed different associations with 
breast cancer risk (i.e., to evaluate an age-dependent window of alcohol susceptibility), we 
performed a sensitivity analysis using self-reported information about drinking patterns for 
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participants over the life course for young age (<25 years), middle age (25-≤49 years of age) 
and older age (50 or more years of age). In subanalyses, we evaluated confounding by 
drinking in prior life periods, restricting to women who were 50 or older and who had 
provided data on young and middle age drinking.
RESULTS
Recent Alcohol Use and Breast Cancer Risk Overall by Race
Frequency of self-reported alcohol drinking among African American and white control 
participants is shown in Table 1. African Americans were more likely to report being Never 
Drinkers and had lower alcohol intake than whites across all age groups. During the period 
prior to enrollment, light drinking (0-≤2) was more prevalent among African Americans, and 
moderate to heavy drinking remained more prevalent in whites (Table 1). African American 
women had significantly elevated risk of invasive breast cancer when reporting more than 7 
drinks per week prior to diagnosis in both the basic and full model [Basic OR, 95% CI: 1.73 
(1.16–2.58); Full OR, 95% CI: 1.62 (1.03–2.54)]. In contrast, white women showed 
marginally increased risk following adjustment at the highest level of drinking [Basic OR, 
95% CI: 1.23 (0.91–1.66); Full OR, 95% CI: 1.20 0.8701.67)] (Table 2).
Recent Alcohol Drinking and Invasive Breast Cancer Subtype
Subtype specific analyses of alcohol-associated risk showed findings similar to breast cancer 
overall. African American women who drank at least 7 drinks per week showed increased 
risk of invasive breast cancer for each hormone receptor (ER+, ER−) and intrinsic subtype 
(luminal A and B combined (ER+ and/or PR+, HER2+/−), triple negative (ER−, PR−, 
HER2−), and basal-like ((ER−, PR−, HER2−, and EGFR+ or CK5/6+) in both the basic and 
full models. Odds ratios for more than 7 drinks per week were statistically significant among 
African American women diagnosed with ER− and triple negative breast cancers (Table 3.) 
Dose-response patterns tended to be nonlinear for luminal and ER positive breast cancer, 
with increased risk in the highest category of alcohol drinking among African American and 
white women. While some of these associations were not significant following adjustment 
for potential confounders, the magnitudes of the ORs were very similar in the basic and full 
models (Table 3).
Many papers have used light drinking as a reference category for alcohol intake because of a 
tendency for alcohol to produce a ‘i-shaped curve’, where risk is higher among both never 
drinkers and moderate-to-heavy drinkers. We did not observe strong evidence for this curve 
in our study. Among African Americans, never drinkers were not at elevated risk, and even 
seemed to be at lower risk of invasive breast cancer subtypes. For white women, we 
observed suggestive evidence of a j-shaped curve among ER-negative, triple negative, and 
basal-like cases, but only with regard to the elevation of risk in never drinkers (Table 3). 
There was no evidence of increased risk among white women who reported moderate or 
high levels of drinking for any of the subtypes. Among white women, we also observed a 
significantly decreased risk of triple negative invasive breast cancer for those drinking more 
than 7 drinks per week and a significantly increased risk of ER− breast cancer among never 
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drinkers. These associations were significant following adjustment for potential 
confounders.
Windows of Susceptibility for Alcohol Intake and Invasive Breast Cancer
Among African American women, we observed an increased risk for the highest category of 
drinking in all three age groups, with statistically significant increases in the younger than 
25 years of age and 50 years of age and older categories. For white women, we observed that 
middle and older age exposure showed the greatest elevation of risk associated with 
drinking, but none of these elevated ORs were significant. Because previous drinking may 
confound estimates associated with current or recent use, we conducted an exploratory 
sensitivity analysis restricting to women diagnosed with invasive breast cancer or enrolled in 
the study at age 50 or older, adjusting for drinking during the two previous age intervals. 
Among African American women, there was a significantly increased risk for invasive 
breast cancer among the never drinkers [Full OR, 95% CI: 2.03 (1.15–3.58)] and the highest 
category of intake [Full OR, 95% CI: 3.27 (1.16–9.23)] when controlling for lifetime intake. 
Odds ratios were not substantially changed after adjusting for previous drinking behavior for 
white women.
Modification of Alcohol-Associated Risk by Oral Contraceptives or Smoking
We did not observe evidence of statistical interaction between recent alcohol intake and oral 
contraceptive use in the basic or full model for African American or white women (African 
American, p= 0.06 and p=0.08; white, p=0.70 and p=0.70; basic and full models, 
respectively). Supplemental Figures 1a and 1b show magnitude of these ORs. Similarly with 
smoking, we did not observe evidence of statistical interaction (African American, p= 0.99 
and p=0.98; white, p=0.08 and p=0.05; basic and full models, respectively). Supplemental 
Figure 2a and 2b show that confidence intervals were wide for cross-classification of alcohol 
use and smoking within race strata.
DISCUSSION
In this case-control study of alcohol intake and invasive breast cancer risk among both 
African American and white women, we found that alcohol intake of more than 7 drinks per 
week in the time period most proximal to diagnosis significantly increased risk for invasive 
breast cancer among African American women with a weak increase in risk among white 
women. We evaluated hormone receptors and intrinsic subtype and found limited evidence 
for heterogeneity of the risk relationships according to breast cancer characteristics. 
However, we did observe significantly elevated ORs for ER− and triple negative breast 
cancers among African American, but not white women. Associations did not vary strongly 
by age of exposure, and were not strongly modified by oral contraceptive use or smoking 
status. However, differences in risk according to race suggest other genetic or environmental 
factors may be important modifiers of the alcohol-breast cancer association.
Previous reports on alcohol intake and invasive breast cancer, including two meta-analyses, 
have been conducted primarily among white women and have consistently found highest 
risk in non-drinkers and the heaviest drinkers, regardless of type of beverage 
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consumed1–4,7,27–30. Among white women, this could be due to non-drinkers having 
comorbidities that necessitate avoiding alcohol. While we do observe slight elevation of risk 
among white non-drinkers in our study, we did not see this curve morphology among 
African American women in our study. The absence of elevated risk in the African 
American non-drinkers could reflect cultural differences where healthy African American 
women choose not to drink due to religious or cultural reasons31. The previous report in 
Phase I of the CBCS did not find any association between alcohol intake and invasive breast 
cancer risk, but did not stratify by race6. The variability in effect estimates across studies and 
according to race suggests that unknown modifiers may play an important role in the 
association between alcohol intake and invasive breast cancer.
Previous studies suggest that alcohol increases risk of ER-positive breast cancer7,13,27,30,32. 
In this study we did not observe a significant increase in ER-positive breast cancer risk for 
African American or white women. Results for ER-positive breast cancers were similar to 
those for Luminal A (ER+/PR+/HER2−) and Luminal B (ER+/PR+/HER2+) invasive breast 
cancers. While the associations in our study were not statistically significant, we note that 
the direction of association was similar, but lower in magnitude than those of Li et al. (2010) 
in postmenopausal women, the meta-analysis of Suziki et al. (2008), the Nurses’ Health 
Study findings by Chen et al. (2011), and work by Terry et al. (2006) for white women from 
the Long Island Breast Cancer Study Project1,7,13,30. We observed stronger associations 
between alcohol use and ER− and triple negative breast cancers. Among white women, we 
observed a suggestion of a protective effect of high alcohol intake relative to triple negative 
breast cancer, which was also observed in the Women’s Health Initiative study32. However, 
this association was qualitatively reversed among African American women, where the 
highest category of alcohol use was associated with a nearly two fold increased risk of 
invasive, triple negative breast cancers. There may be many explanations for why 
associations between alcohol intake and ER− and triple negative breast cancer in this study 
differ from those previously reported, but alcohol-breast cancer associations have not been 
well studied in African American women. Notably, associations were similar between triple 
negative (ER−, PR−, HER2−), and basal-like (ER−, PR−, HER2−, and EGFR+ or CK5/6+), 
suggesting that a more restrictive definition of basal-like that includes CK5/6+ and EGFR+ 
did not markedly alter associations.
When we conducted sensitivity analyses to identify age-defined windows of susceptibility to 
alcohol use, we found that the highest category of alcohol intake (>7 drinks/day) 
significantly increased risk in the youngest and oldest categories (<25and 50+ years of age) 
for African Americans, but only the 50+ highest intake category showed an elevated, though 
not significant, risk for white women (Table 4). Terry et al. (2006) also found increased risk 
in the highest intake category (≥15g/day) among women from 30–40 years of age, 40–50, 
and 50–607, primarily among white women. Similarly, Chen et al. (2011) found that 
previous alcohol intake (>5g/day), current drinking, and cumulative exposure all 
significantly increased breast cancer risk among white women30. Tjonnenland et al. (2007) 
did not report a significant association for increased risk for each 10g/day increase among 
age periods from 20–40 years of age2. We also examined intake in the 50+ category when 
controlling for drinking in the two prior categories and found significantly elevated risks 
among African American women for the youngest and oldest age categories (<25 and 50+ 
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years of age) in the categories for 0 drinks per week and more than 7 drinks per week. These 
data provide little support for a specific window of susceptibility to alcohol use, and are 
consistent with data suggesting that alcohol may have both early and late effects on the 
carcinogenic process12.
Strong differences by race may be caused by a different prevalence of an environmental or 
genetic modifying exposure. We ruled out two important exposures as effect modifiers in 
this study. First, we evaluated oral contraceptive use, considering that alcohol intake has 
been hypothesized to increase levels of bioavailable hormones15, particularly among women 
taking oral contraceptives12,33. Our results showed weak evidence of interaction between 
alcohol and oral contraceptives, consistent with Dumeaux et al. (2004)34. Second, we 
evaluated smoking status as a possible modifier of alcohol-associated risk. The results 
among white women were similar to those reported by Hamajima et al. (2002) in a large 
meta-analysis where ever smokers were not at an increased risk of breast cancer when 
compared to never smokers at any level of intake29. We did observe a significantly elevated 
risk for African American women who reported being current smokers in the highest intake 
category. Future research should explore other genetic or environmental modifiers that 
account for differences by race. For example, there is some evidence that there may be 
genetic differences in alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) 
by race35,36, and both genes play important roles in alcohol metabolism.
Our findings should be interpreted in light of some limitations. CBCS is a case-control study 
and information on alcohol intake was collected after diagnosis for cases. This could lead to 
biased classification of alcohol intake. We cannot be certain of the direction of bias, but the 
Nurses’ Health Study showed that recall bias for alcohol intake after breast cancer diagnosis 
led to underestimation of effect estimates37. CBCS did not collect dietary information so we 
were unable to conduct analysis of how dietary patterns may modify alcohol-associated risk, 
and we had limited power to evaluate statistical interactions. We therefore emphasized racial 
differences and evaluated only the most commonly studied effect modifiers of the alcohol-
breast cancer association, emphasizing magnitude of change over statistical significance. We 
were unable to evaluate the effects of drinking more than 7 drinks per week or specific types 
of alcoholic beverages. Few participants reported intake levels in the higher categories and 
we had insufficient numbers of participants in each category of specific alcohol beverage 
type, but previous studies examining beverage type have typically shown strongest 
associations for the beverage type consumed most commonly. Finally, while we had 
information on exposure in different age-defined windows, these windows were relatively 
large and we were unable to account for complex changes in exposure over time within these 
windows. There was a larger degree of missing data for the analysis restricted to women 
aged 50 years or older due to oversampling of younger women in the CBCS, but these 
exploratory sensitivity analyses were included as a preliminary assessment of windows of 
susceptibility. In spite of these limitations, our study provides compelling evidence of some 
differences in alcohol-associated risk of breast cancer in African American versus white 
women.
In summary, we found evidence for modification of the alcohol associated breast cancer risk 
by race, and for subtype-specific effects of alcohol on triple negative and ER− breast cancer. 
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Our findings differ from results in predominantly white studies, suggesting a need for 
research on the genetic and environmental modifiers of alcohol-associated breast cancer risk 
among African American and white women.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Table 1
Distribution of Alcohol Intake among African American and white controls from the Carolina Breast Cancer 
Study, Phase I (1993–1996) and Phase II (1996–2001)
African American White P-value*
N (%) N (%)
Total 714 844
Alcohol
  Never 276 (40.4) 230 (22.4) <0.0001
  Ever 438 (59.6) 614 (77.6)
Drinks per week <25 years of age
  0 372 (51.2) 396 (35.5) <0.0001
  >0–≤2 171 (26.1) 254 (26.6)
  >2–≤7 110 (15.7) 127 (29.7)
  >7 60 (7.0) 65 (8.2)
  Missing 1 2
Drinks per week 25–<49 years of age
  0 342 (49.5) 273 (30.4) <0.0001
  >0–≤2 194 (30.5) 319 (39.2)
  >2–≤7 104 (12.1) 160 (20.4)
  >7 74 (7.9) 88 (10.0)
  Missing 0 4
Drinks per week 50+ years of age
  0 252 (70.9) 196 (46.3) <0.0001
  >0–≤2 63 (17.6) 122 (29.7)
  >2–≤7 28 (8.4) 62 (14.6)
  >7 10 (3.1) 42 (9.4)
  Missing 361 422
Drinks per week prior to enrollment
  Never Drinker 276 (40.4) 230 (22.4) <0.0001
  0–≤2 314 (44.3) 368 (40.5)
  >2–≤7 78 (9.8) 152 (28.1)
  >7 46 (5.5) 94 (9.1)
*Wald Chi-square test for association excludes missing data and accounts for sampling strata
a
Frequencies are unweighted and percentages are adjusted for sampling fractions.
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